A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design

Schmidt-Kraepelin, ChristianChristianSchmidt-KraepelinFeyerabend, SandraSandraFeyerabendEngelke, ChristinaChristinaEngelkeRiesbeck, MathiasMathiasRiesbeckMeisenzahl-Lechner, EvaEvaMeisenzahl-LechnerGaebel, WolfgangWolfgangGaebelVerde, Pablo-EmilioPablo-EmilioVerdeKolbe, HenrikeHenrikeKolbeCorrell, Christoph U.Christoph U.CorrellLeucht, StefanStefanLeuchtHeres, StephanStephanHeresKluge, MichaelMichaelKlugeMakiol, ChristianChristianMakiolNeff, AndreaAndreaNeffLange, ChristinaChristinaLangeEnglisch, SusanneSusanneEnglischZink, MathiasMathiasZinkLangguth, BertholdBertholdLangguthPoeppl, TimmTimmPoepplReske, DirkDirkReskeGouzoulis-Mayfrank, EuphrosyneEuphrosyneGouzoulis-MayfrankGründer, GerhardGerhardGründerHasan, AlkomietAlkomietHasanBrockhaus-Dumke, AnkeAnkeBrockhaus-DumkeJäger, MarkusMarkusJägerBaumgärtner, JessicaJessicaBaumgärtnerWobrock, ThomasThomasWobrockCordes, JoachimJoachimCordes2020-12-102020-12-1020190940-1334https://resolver.sub.uni-goettingen.de/purl?gro-2/70788enA randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and designjournal_article10.1007/s00406-019-01063-41433-8491